3-Jahres-Update zur Therapie mit Tebentafusp beim metastasierten Uveamelanom

J Dtsch Dermatol Ges. 2024 Mar;22(3):485-487. doi: 10.1111/ddg.15391_g.
[Article in German]
No abstract available

MeSH terms

  • Humans
  • Melanoma*
  • Neoplasms, Second Primary*
  • Recombinant Fusion Proteins*
  • Uveal Neoplasms*

Substances

  • tebentafusp
  • Recombinant Fusion Proteins

Supplementary concepts

  • Uveal melanoma